State Street Research Articles

Eaton Vance Corp

Mergent's Dividend AchieversVolume 3, Issue 2 p. 91-91 U.S. Company Reports Eaton Vance Corp† First published: 20 April 2006 https://doi.org/10.1002/div.3899 † Contact: : James B. Hawkes — Chmn., Pres., C.E.O. Address: : 255 State Street, Boston, MA 02109 Web Site: : www.eatonvance.com AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Abstract Wealth Management (MIC: 8.8 SIC: 6282 NAIC: 523930) Eaton Vance is engaged in creating, marketing and managing investment companies and providing investment management and counseling services to high-net-worth individuals and institutions. Co. offers investment management service in a range of asset classes - tax-managed equities, value equities, real estate, municipal bonds, floating-rate bank loans, mortgage-backed securities global currency and income investments, high grade bonds and high yield bonds. Also, Co. provides investment advisory services to funds, retail managed accounts, institutional separate accounts and high-net-worth separate accounts. Volume3, Issue2Spring 2006Pages 91-91 RelatedInformation

On the Feasibility of Improving Patent Quality One Technology at a Time: The Case of Business Methods

Following the Federal Circuit's 1998 decision in State Street Bank & Trust Co. v. Signature Financial Group, Inc. holding that there was no per se exclusion from patentability for software-implemented business methods, the number of applications for and grants of such patents on increased dramatically. A large number of critics castigated them for two primary reasons: First, some contended that patents should simply not be allowed on such subject matter. Second, a much larger number of critics asserted that these patents were of singularly inferior quality because they had been issued without due consideration to the relevant prior art-documentary evidence of what others had done in the past. In response to these criticisms, the United States Patent and Trademark Office (PTO) instituted an initiative in March 2000 that it called the Second Pair of Eyes Review, intended to make it more difficult to obtain business method patents. Among other features, the SPER program called for a second-level review upon allowance for patent applications in Main Class 705. Each of the authors had independently conducted previous research leading us to conclude that software-implemented business method patents cited prior art that was not inferior in quantity or quality to other types of patents, and that the many prior art-related criticisms were not supported by empirical evidence. Although some business method patents undoubtedly were of low quality, one finds low-quality patents in all fields. Be that as it may, we believe it important to empirically assess the effects of the SPER initiative. The program requires substantial resources, and if it has not had significant positive effects, these wasted resources constitute a tax on innovation because the PTO is supported by user fees. Perhaps a more important reason for evaluating SPER's effects, however, is that the PTO declared it to be a success and announced plans to expand it to other fields. Whether or not the agency expands the program in the near term, it is important to know whether targeting patent reforms at particular technology fields is a model that should ever be replicated. Employing negative binomial regression models, we found that the SPER initiative did indeed have significant positive effects on the quantity and quality of prior art cited in patent applications to which it applied. Using logistic regression, we determined that the SPER initiative also led to a significant increase in the number of Main Class 705 patents that cited at least some prior art. Moreover, we found that, after SPER, examiners themselves added significantly more prior art references that did examiners of closely related patents with Secondary 705 classifications. Success within this narrow operative domain, however, is seriously tempered by a number of factors, leading to the conclusion that attempting to improve patent quality one technology at a time is not a model that should be repeated. Because of definitional problems that are impossible to overcome, and because the patent classification system is very poorly suited for this kind of task, such an approach to patent reform is and always will be grossly underinclusive and subject to gaming by both patent applicants and beleaguered patent examiners. Attempts to improve patent quality should not focus on a single field.

State Street Corp.

State Street Corp.

Ambac Financial Group, Inc.

Mergent's Dividend AchieversVolume 3, Issue 4 p. 11-11 U.S. Company Reports Ambac Financial Group, Inc.† First published: 10 October 2006 https://doi.org/10.1002/div.4654 † Contact: : Phillip B.Lassiter — Chmn. Address: : One State Street Plaza, New York, NY 10004 Web Site: : www.ambac.com AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Insurance (MIC: 8.2 SIC: 6351 NAIC: 524130) Ambac Financial Group is a holding company whose subsidiaries provide financial guarantee products and other financial services to clients in the public and private sectors. Co. provides financial guarantees for public finance and structured finance obligations through its principal operating subsidiary, Ambac Assurance. Also, Co. provides financial and investment products including investment agreements, interest rate and total return swaps and funding conduits, primarily to its clients of the financial guarantee business, which include municipalities and other public entities, health care organizations and asset-backed and structured finance issuers. Volume3, Issue4Autumn (Fall) 2006Pages 11-11 RelatedInformation

Eaton Vance Corp

Mergent's Dividend AchieversVolume 3, Issue 4 p. 90-90 U.S. Company Reports Eaton Vance Corp† First published: 10 October 2006 https://doi.org/10.1002/div.4733 † Contact: : James B. Hawkes — Chmn., Pres., C.E.O. Address: : 255 State Street, Boston, MA 02109 Web Site: : www.eatonvance.com AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Wealth Management (MIC: 8.8 SIC: 6282 NAIC: 523930) Eaton Vance is engaged in creating, marketing and managing investment companies and providing investment management and counseling services to high-net-worth individuals and institutions. Co. offers investment management service in a range of asset classes - tax-managed equities, value equities, real estate, municipal bonds, floating-rate bank loans, mortgage-backed securities global currency and income investments, high grade bonds and high yield bonds. Also, Co. provides investment advisory services to funds, retail managed accounts, institutional separate accounts and high-net-worth separate accounts. Volume3, Issue4Autumn (Fall) 2006Pages 90-90 RelatedInformation

Cardiac Calendar—2006 to 2007

Twenty-Fourth Annual Symposium. Clinical Update in Anesthesiology. St. Thomas, US Virgin Islands. January 14-21, 2006. Contact: H. Phillips, Mt. Sinai Medical Center, 1 Gustave L. Levy Place, Box 1010, New York, NY 10029. E-mail: [email protected] Second World Congress of Regional Anesthesia and Pain Therapy. Rio de Janeiro, Brazil. February 22-26, 2006. Contact: Options Eurocongress Rue de l’Instruction, 126B, B-1070 Brussels, Belgium. Eleventh Update on Cardiopulmonary Bypass. Whistler, British Columbia, Canada. March 12-18, 2006. Contact: SCA, PO Box 11086, 2209 Dickens Road, Richmond, VA 23230-1086. Eightieth Clinical and Scientific Congress of the International Anesthesia Research Society. San Francisco, CA. March 24-28, 2006. Contact: IARS 2 Summit Park Drive #140, Cleveland, OH 44131. Aortic Surgery–Symposium X. New York, NY. April 27-28, 2006. Contact: Promedica International, 2333 State Street, Carlsbad, CA 92008. Society of Cardiovascular Anesthesiologists Twenty-Eighth Annual Meeting and Workshops. San Diego, CA. April 29th-May 3, 2006. Contact: SCA, PO Box 11086, 2209 Dickens Road, Richmond, VA 23230-1086. Association of University Anesthesiologists Fifty-Third Annual Meeting. Tucson, AZ. May 11-13, 2006. Contact: AUA, 520 N. Northwest Highway, Park Ridge, IL 60068. Twenty-First Annual Meeting of the European Association of Cardiothoracic Anesthesiologists. Venice, Italy. May 24-27, 2006. Contact: Kerri James, Easy Congress, Via dei Canzi 18, 20134 Milano, Italy. Fourteenth Annual Meeting of the Asian Society for Cardiovascular Surgery. Osaka, Japan. June 1-3, 2006. Contact: National Cardiovascular Center, 5-7-1 Fujishirodai, Suito, Osaka, 565-8565 Japan. World Congress of the World Society of Cardiothoracic Surgeons. Ottawa, Canada. August 17-20, 2006. Contact: D. Hasle, University of Ottawa, Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7. Tenth International Congress of Cardiothoracic and Vascular Anesthesia. Prague, Czech Republic. August 27-30, 2006. Contact: Guarant, Ltd. Opletalovo 22, 11000 Prague 1, Czech Republic. American Society of Anesthesiologists Annual Meeting. Chicago, IL. October 14-18, 2006. Contact: ASA, 520 N Northwest Highway, Park Ridge, IL 60068. Twelfth Asian Australian Congress of Anesthesiologists. Singapore. November 6-10, 2006. Contact: AACA Congress Secretariat, 73 Bukit Timah Road, Rex House, Unit 03-01, Singapore 229832. Sixtieth Postgraduate Assembly in Anesthesiology, New York State Society of Anesthesiology. New York, NY. December 8-12, 2006. Contact: NYSSA, 85 Fifth Avenue, New York, NY 10003. Association of University Anesthesiologists Fifty-Fourth Annual Meeting. Chicago, IL. April 26-28, 2007. Contact: AUA, 520 N Northwest Highway, Park Ridge, IL 60068. American Society of Anesthesiologists Annual Meeting. San Francisco, CA. October 13-17, 2007. Contact: ASA, 520 N Northwest Highway, Park Ridge, IL 60068 Sixty-First Postgraduate Assembly in Anesthesiology, New York State Society of Anesthesiology. New York, NY. December 7-11, 2007. Contact: NYSSA, 85 Fifth Avenue, New York, NY 10003. The Journal of Cardiothoracic and Vascular Anesthesia welcomes announcements of interest to physicians, researchers, and others concerned with cardiothoracic and vascular anesthesiology, medicine, pharmacology, and related areas. All copies are reviewed and edited for style, clarity, and length. Information is due at least 90 days before the date of publication and should be addressed to George Silvay, MD, PhD, Editor, Department of Anesthesiology, Mount Sinai Medical Center, 1 Gustave L. Levy Place, Box 1010, New York, NY 10029-6574.

Pituitary hormones and systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is known for its predominant occurrence in women and for its peak incidence during the reproductive years. The increased ratio of female to male SLE patients implies that sex-associated genetic and/or endocrine factors modulate disease proclivity and development. While chromosome differences or sex-associated metabolic or environmental factors may underlie the predominant occurrence of SLE in women, no relationship with the disease has proven stronger than those of female sex and female/male differences in sex hormones. This concept has been supported not only by epidemiologic studies, but also by substantial evidence of the immunoregulatory actions of 17 -estradiol (estradiol), testosterone, progesterone, dehydroepiandrosterone (DHEA)/ DHEA sulfate, and prolactin (1–4). A recent review and meta-analysis of data examining sex hormone abnormalities in SLE patients revealed that female SLE patients had significantly depressed concentrations of androgens and elevated concentrations of estradiol compared not only with their male counterparts with SLE but also with healthy controls (5). In addition, both female and male SLE patients had abnormally elevated serum prolactin concentrations, and in male SLE patients, elevation of serum prolactin concentrations was the only sex hormone aberration clearly identified in meta-analyses (5). Elevated prolactin concentrations in SLE patients (4,5), regulation of sex steroids by pituitary gonadotropins (6,7), interdependence of neuroendocrine and immune systems (8), and effects of inflammatory cytokines on pituitary function (9,10) evoke the possibility that pituitary hormone abnormalities contribute to or synergize with the altered sex steroids contributing to SLE disease expression. Investigations of pituitary hormones in SLE have been relatively uniform in their enrollment of patients and appropriately matched healthy controls. However, small numbers of study participants, variability in interand intrastudy results, long time intervals over which comparisons have been reported, and absence of sufficient statistical power to test respective hypotheses have limited the conclusions and possibly obscured the identification of important relationships between SLE and pituitary hormonal immunomodulation. Furthermore, peptide hormone/steroid/cytokine feedback loops, hormonal interconversions (e.g., DHEA to testosterone and/or estradiol), and the superimposed hourly, daily, and monthly chronobiologic variations of menses, pregnancy, and/or hormone administration complicate a simple interpretation of these cause-and-effect relationships as well as successful application of hormonal immunotherapy. We review herein the investigations of adenohypophyseal hormones—follicle-stimulating hormone (FSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH), thyroid-stimulating hormone (TSH), growth hormone (GH), and prolactin—in patients with SLE. These anterior pituitary hormones are peptides of various molecular weights that bind to surface receptors and stimulate a variety of actions (6,7). They can affect the immune system directly (11) or indirectly through their effects on the synthesis of sex steroids with immunomodulatory capacity (1–4). Moreover, manipulation of serum pituitary hormones has been shown to be immunoregulatory, especially in animal models (11–15). In order to better understand the associations between SLE, sex, and pituitary hormones, clinical studies measuring serum concentrations of FSH, LH, ACTH, TSH, and GH (as well as prolactin) in nonpregnant adult women and men with SLE were identified by a computSupported by the Mississippi Lupus Association. Jing Li, MD, Warren May, PhD, Robert W. McMurray, MD: University of Mississippi Medical Center, Jackson. Address correspondence and reprint requests to Robert W. McMurray, MD, Division of Rheumatology and Molecular Immunology, L525 Clinical Sciences Building, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216. E-mail: Robert.McMurray@medicine.umsmed.edu. Submitted for publication March 9, 2005; accepted in revised form August 25, 2005.

Minimally Invasive Spine Surgery

Dr. Wang is Assistant Professor and Spine Director, Dr. Kim is Clinical Instructor, and Dr. Hoh is Clinical Instructor, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, 1200 North State Street, #5046, Los Angeles, CA; E-mail: [email protected]. From the Editor: I am very pleased to announce that retroactive to Volume 25, Issue 1, the American Association of Neurological Surgeons attests that this educational activity has been recognized for co-sponsored/endorsement for 1.5 Category 1 CME credits of the American Association of Neurological Surgeons' Continuing Education Award in Neurosurgery. Dr. Wang has disclosed that he receives direct grant/research funding from DePuy Spine, Inc. Dr. Kim and Dr. Ho have disclosed that they have no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. The authors have disclosed that the use of the Vertelink device for treatment of spinal instability has not been approved by the U.S. Food and Drug Administration. Wolters Kluwer Health has identified and resolved all faculty conflicts of interest regarding this educational activity. Category: Spine

On the Feasibility of Improving Patent Quality One Technology at a Time: The Case of Business Methods

Following the Federal Circuit's 1998 decision in State Street Bank & Trust Co. v. Signature Financial Group, Inc. holding that there was no per se exclusion from patentability for software-implemented business methods, the number of applications for and grants of such patents on increased dramatically. A large number of critics castigated them for two primary reasons: First, some contended that patents should simply not be allowed on such subject matter. Second, a much larger number of critics asserted that these patents were of singularly inferior quality because they had been issued without due consideration to the relevant prior art-documentary evidence of what others had done in the past. In response to these criticisms, the United States Patent and Trademark Office (PTO) instituted an initiative in March 2000 that it called the Second Pair of Eyes Review, intended to make it more difficult to obtain business method patents. Among other features, the SPER program called for a second-level review upon allowance for patent applications in Main Class 705. Each of the authors had independently conducted previous research leading us to conclude that software-implemented business method patents cited prior art that was not inferior in quantity or quality to other types of patents, and that the many prior art-related criticisms were not supported by empirical evidence. Although some business method patents undoubtedly were of low quality, one finds low-quality patents in all fields. Be that as it may, we believe it important to empirically assess the effects of the SPER initiative. The program requires substantial resources, and if it has not had significant positive effects, these wasted resources constitute a tax on innovation because the PTO is supported by user fees. Perhaps a more important reason for evaluating SPER's effects, however, is that the PTO declared it to be a success and announced plans to expand it to other fields. Whether or not the agency expands the program in the near term, it is important to know whether targeting patent reforms at particular technology fields is a model that should ever be replicated. Employing negative binomial regression models, we found that the SPER initiative did indeed have significant positive effects on the quantity and quality of prior art cited in patent applications to which it applied. Using logistic regression, we determined that the SPER initiative also led to a significant increase in the number of Main Class 705 patents that cited at least some prior art. Moreover, we found that, after SPER, examiners themselves added significantly more prior art references that did examiners of closely related patents with Secondary 705 classifications. Success within this narrow operative domain, however, is seriously tempered by a number of factors, leading to the conclusion that attempting to improve patent quality one technology at a time is not a model that should be repeated. Because of definitional problems that are impossible to overcome, and because the patent classification system is very poorly suited for this kind of task, such an approach to patent reform is and always will be grossly underinclusive and subject to gaming by both patent applicants and beleaguered patent examiners. Attempts to improve patent quality should not focus on a single field.

State Street Corp.

AbstractCommercial Banking (MIC: 8.1 SIC: 6022 NAIC: 522110)State Street is a bank holding company, with $94.04 billion in assets as of Dec 31 2004, that conducts business worldwide principally through its subsidiary, State Street Bank and Trust Company. Co. has two lines of business: Investment Servicing provides services for U.S. mutual funds, collective funds worldwide, corporate and public retirement plans, insurance companies, foundations, endowments, and other investment pools. Investment Management offers an array of services for managing financial assets, including investment management and investment research, primarily for institutional investors worldwide.

Paraproteinemias and the lungs

Department of Medicine, Keck School of Medicine, Los Angeles, California, USA Correspondence to Om P. Sharma, Department of Medicine, LAC+USC Medical Center, Room 11-900, 1200 North State Street, Los Angeles, CA 90033, USA Tel: 323 226 7923; fax: 323 226 2738; e-mail: [email protected]

COMBINED POSTERIOR AND CONVERGENT ELBOW DISLOCATIONS IN AN ADULT

1 DO Department of Orthopaedics, Hamot Medical Center, 201 State Street, Erie, PA 16550. E-mail address for C.N. Lippe: [email protected]

State Street Corp.

AbstractCommercial Banking (MIC: 8.1 SIC: 022 NAIC: 22110)State Street is a bank holding company, with $94.04 billion in assets as of Dec 31 2004, that conducts business worldwide principally through its subsidiary, State Street Bank and Trust Company. Co. has two lines of business: Investment Servicing provides services for U.S. mutual funds, collective funds worldwide, corporate and public retirement plans, insurance companies, foundations, endowments, and other investment pools. Investment Management offers an array of services for managing financial assets, including investment management and investment research, primarily for institutional investors worldwide.

Headache Research Methodology: Introduction to the Special Series

Headache Research Methodology: Introduction to the Special Series Donald B. Penzien PhD, Donald B. Penzien PhDSearch for more papers by this author Donald B. Penzien PhD, Donald B. Penzien PhDSearch for more papers by this author First published: 09 June 2005 https://doi.org/10.1111/j.1526-4610.2005.05090.xCitations: 2 Address all correspondence to Donald B. Penzien, PhD, Professor and Director, Head Pain Center, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA. From the Department of Psychiatry and Human Behavior, and Director, Head Pain Center, University of Mississippi Medical Center, Jackson, MS. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume45, Issue5May 2005Pages 408-410 RelatedInformation

Guidelines for Trials of Behavioral Treatments for Recurrent Headache: Purpose, Process, and Product

Guidelines for Trials of Behavioral Treatments for Recurrent Headache: Purpose, Process, and Product Donald B. Penzien PhD, Donald B. Penzien PhDSearch for more papers by this author Donald B. Penzien PhD, Donald B. Penzien PhDSearch for more papers by this author First published: 25 May 2005 https://doi.org/10.1111/j.1526-4610.2005.4502001.xCitations: 4 Address all correspondence to Dr. Donald B. Penzien, Head Pain Center Department of Psychiatry and Human Behavior University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216. From the Department of Psychiatry and Human Behavior, and Director, Head Pain Center, University of Mississippi Medical Center, Jackson, Mississippi. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume45, Issues2May 2005Pages S87-S89 RelatedInformation

Appropriate Pricing and Valuation of Portfolio Companies

Jonathan Boersma, CFA, of the CFA Centre for Financial Market Integrity, and William Franklin, of the Bank of America Capital Corporation and the Private Equity Industry Guidelines Group, each discuss their respective organization's progress in developing valuation guidelines for the private equity industry. They are then joined by Scott Brown, CFA, of State Street Corporation, for a panel question and answer session on private equity valuation guidelines.

Ecological Statistics

EcologyVolume 86, Issue 3 p. 810-811 Book Review Ecological Statistics John M. Drake, John M. Drake National Center for Ecological Analysis and Synthesis 735 State Street, Suite 300 Santa Barbara, California 93101 E-mail: drake@nceas.ucsb.eduSearch for more papers by this author John M. Drake, John M. Drake National Center for Ecological Analysis and Synthesis 735 State Street, Suite 300 Santa Barbara, California 93101 E-mail: drake@nceas.ucsb.eduSearch for more papers by this author First published: 01 March 2005 https://doi.org/10.1890/0012-9658(2005)86[810:ES]2.0.CO;2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume86, Issue3March 2005Pages 810-811 RelatedInformation

State Street Corp.

AbstractCommercial Banking (MIC: 8.1 SIC: 6022 NAIC:522110)State Street is a bank holding company, with $87.53 billion in assets as of Dec 31 2003, that conducts business worldwide principally through its subsidiary, State Street Bank and Trust Company. Co. has two lines of business: investment servicing and investment management. Investment Servicing includes primarily accounting, custody and other services for large pools of assets. Investment management offers index and active equity strategies, short‐term investment funds and fixed income products. As of Dec 31 2003, Co. had $1.10 trillion in assets under management.

Ambac Financial Group, Inc.

Abstract Insurance (MIC: 8.2 SIC: 6351 NAIC:524130)Ambac Financial Group is a holding company whose subsidiaries provide financial guarantee products and other financial services to clients in both the public and private sectors. Co. provides financial guarantees for public finance and structured finance obligations through its principal operating subsidiary, Ambac Assurance. Through its financial services subsidiaries, Co. provides financial and investment products including investment agreements, interest rate and total return swaps and funding conduits, principally to its clients which include municipalities and their authorities, school districts, health care organizations and asset‐backed issuers.

State Street Corp.

State Street Corp.